Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $515.40 | 35 | 85.6% |
| Education | $86.78 | 2 | 14.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $155.03 | 10 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $138.53 | 7 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $98.35 | 7 | $0 (2020) |
| Allergan Inc. | $81.46 | 4 | $0 (2019) |
| Alkermes, Inc. | $56.96 | 4 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $39.97 | 2 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $19.00 | 1 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $12.88 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $42.02 | 3 | Janssen Pharmaceuticals, Inc ($27.74) |
| 2019 | $246.56 | 13 | Teva Pharmaceuticals USA, Inc. ($122.33) |
| 2018 | $156.51 | 10 | Sunovion Pharmaceuticals Inc. ($39.97) |
| 2017 | $157.09 | 11 | Otsuka America Pharmaceutical, Inc. ($47.39) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/04/2020 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Neuroscience | ||||||
| 04/13/2020 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Neuroscience | ||||||
| 02/11/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $6.17 | General |
| Category: Central Nervous System | ||||||
| 10/08/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Central Nervous System | ||||||
| 10/07/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $0.46 | General |
| Category: Central Nervous System | ||||||
| 09/23/2019 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $85.50 | General |
| 08/29/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: PSYCHIATRY | ||||||
| 06/11/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: PSYCHIATRY | ||||||
| 04/23/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Neuroscience | ||||||
| 03/12/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: NEUROLOGY | ||||||
| 02/26/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $3.11 | General |
| Category: Central Nervous System | ||||||
| 01/29/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: CNS | ||||||
| 01/09/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Central Nervous System | ||||||
| 12/11/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Neuroscience | ||||||
| 11/13/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: CNS | ||||||
| 06/12/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: Neuroscience | ||||||
| 05/08/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: CNS | ||||||
| 04/10/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: PSYCHIATRY | ||||||
| 03/13/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Central Nervous System | ||||||
| 01/30/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 223 | 316 | $91,862 | $28,917 |
| 2022 | 7 | 371 | 461 | $116,792 | $41,752 |
| 2021 | 10 | 565 | 761 | $156,819 | $53,912 |
| 2020 | 10 | 580 | 1,119 | $197,110 | $59,824 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 100 | 101 | $39,794 | $12,839 | 32.3% |
| 90870 | Therapy using electrical currents | Office | 2023 | 17 | 81 | $27,540 | $6,520 | 23.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 70 | $9,660 | $3,998 | 41.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 36 | $9,324 | $3,308 | 35.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 28 | $5,544 | $2,252 | 40.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 100 | 100 | $32,583 | $12,307 | 37.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 91 | 96 | $28,992 | $9,420 | 32.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 54 | 101 | $19,785 | $7,566 | 38.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 58 | 89 | $12,090 | $4,723 | 39.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 34 | $12,886 | $4,636 | 36.0% |
| 90870 | Therapy using electrical currents | Office | 2022 | 13 | 19 | $6,308 | $1,551 | 24.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 21 | 22 | $4,148 | $1,550 | 37.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 198 | 247 | $55,400 | $17,426 | 31.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 63 | 66 | $18,594 | $8,303 | 44.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 49 | 147 | $23,061 | $7,844 | 34.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 104 | $15,571 | $4,549 | 29.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 42 | 43 | $12,992 | $4,369 | 33.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 19 | $7,201 | $2,853 | 39.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 30 | $6,334 | $2,326 | 36.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 15 | 15 | $4,749 | $2,007 | 42.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 26 | 26 | $5,467 | $1,865 | 34.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 18 | 23 | $3,779 | $1,186 | 31.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 17 | 41 | $3,672 | $1,185 | 32.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 237 | 467 | $99,483 | $29,231 | 29.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 148 | 207 | $29,319 | $8,944 | 30.5% |
About Dr. William Michael, M.D
Dr. William Michael, M.D is a Psychiatry healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427162882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Michael, M.D has received a total of $602.18 in payments from pharmaceutical and medical device companies, with $42.02 received in 2020. These payments were reported across 37 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($515.40).
As a Medicare-enrolled provider, Michael has provided services to 1,739 Medicare beneficiaries, totaling 2,657 services with total Medicare billing of $184,405. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Lincoln, NE
- Active Since 08/19/2006
- Last Updated 08/20/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1427162882
Products in Payments
- INVEGA SUSTENNA (Drug) $98.35
- REXULTI (Drug) $87.69
- ABILIFY MAINTENA (Drug) $67.34
- VRAYLAR (Drug) $63.28
- AUSTEDO (Drug) $53.03
- Aristada 441 mg (Drug) $41.98
- LATUDA (Drug) $39.97
- INGREZZA (Drug) $19.00
- NAMZARIC (Drug) $18.18
- ARISTADA (Drug) $14.98
- Trintellix (Drug) $12.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Lincoln
Dr. Walter Duffy, Md, MD
Psychiatry — Payments: $113,922
Dr. James Whalen, M.d, M.D
Psychiatry — Payments: $22,244
Dianna Clyne, M.d, M.D
Psychiatry — Payments: $18,948
Jeffrey Coffman, M.d, M.D
Psychiatry — Payments: $17,744
Kelli Bremer, M.d, M.D
Psychiatry — Payments: $12,411
Dr. Heather Abrahams, Md, MD
Psychiatry — Payments: $8,829